ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
暂无分享,去创建一个
S. Steinberg | J. Minna | A. Gazdar | H. Pass | J. Mulshine | T. Mitsudomi | J. Viallet | R. Phelps | H. Oie
[1] J. Minna,et al. Recessive oncogenes and chromosomal deletions in human lung cancer , 1989 .
[2] M. Barbacid. ras genes. , 1987, Annual review of biochemistry.
[3] S. Rodenhuis,et al. K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.
[4] J. L. Bos,et al. ras oncogenes in human cancer: a review. , 1989, Cancer research.
[5] S. Rodenhuis,et al. Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung. , 1987, The New England journal of medicine.
[6] G. Deng,et al. Correlation of mutations of oncogene C-Ha-ras at codon 12 with metastasis and survival of gastric cancer patients. , 1991, Oncogene research.
[7] F. McCormick,et al. N-ras gene point mutations in childhood acute lymphocytic leukemia correlate with a poor prognosis. , 1990, Blood.
[8] L. Liotta,et al. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. , 1985, The American journal of pathology.
[9] H. Hansen,et al. Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.
[10] M. Israel,et al. Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin. , 1988, Cancer research.
[11] M. Sklar. The ras oncogenes increase the intrinsic resistance of NIH 3T3 cells to ionizing radiation. , 1988, Science.
[12] C. Harris,et al. Human bronchial epithelial cells neoplastically transformed by v-Ki-ras: altered response to inducers of terminal squamous differentiation. , 1988, Oncogene research.
[13] N. Mantel. Evaluation of survival data and two new rank order statistics arising in its consideration. , 1966, Cancer chemotherapy reports.
[14] A. Gazdar,et al. Cell culture methods for human lung cancer. , 1986, Cancer genetics and cytogenetics.
[15] R. Katakura,et al. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1991, Oncogene.
[16] R. Kumar,et al. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. , 1989, Oncogene research.
[17] E. Kaplan,et al. Nonparametric Estimation from Incomplete Observations , 1958 .
[18] C. Der,et al. Biological and biochemical properties of human ras H genes mutated at codon 61 , 1986, Cell.
[19] C. Mountain,et al. A new international staging system for lung cancer. , 1987, Chest.
[20] J. Guillem,et al. Rapid detection of ras oncogenes in human tumors: applications to colon, esophageal, and gastric cancer. , 1989, Oncogene.
[21] T. Sekiya,et al. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. , 1990, Oncogene.
[22] S. Rodenhuis,et al. Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung. , 1988, Cancer research.
[23] J. Minna,et al. Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines. , 1991, Oncogene.
[24] D.,et al. Regression Models and Life-Tables , 2022 .
[25] M. Sklar. Increased resistance to cis-diamminedichloroplatinum(II) in NIH 3T3 cells transformed by ras oncogenes. , 1988, Cancer research.
[26] R. Makuch,et al. myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course. , 1987, The Journal of clinical investigation.
[27] M. Schwab,et al. Amplification of cellular oncogenes: A predictor of clinical outcome in human cancer , 1990, Genes, chromosomes & cancer.